Duodenal Ulcer
Background
A duodenal ulcer (DU) is a type of peptic ulcer disease (PUD) characterized by acid-induced injury to the lining of the duodenum, the first part of the small intestine. [1] Peptic ulcers can also occur in the stomach (gastric ulcers) or other parts of the digestive tract. [1] Duodenal ulcers are a common gastrointestinal disorder, contributing to the global burden of peptic ulcer disease. [1] The presence of duodenal ulcers is typically identified through disease diagnoses from various sources, including hospital admissions, primary care records, and self-reporting. [2]
Biological Basis
The development of duodenal ulcers is multifactorial, involving both environmental factors and host genetic susceptibility. [2] A primary environmental factor is infection with Helicobacter pylori (H. pylori), a bacterium known to cause inflammation and damage to the duodenal lining. [2] Genetic factors are recognized to contribute significantly to PUD, including duodenal ulcers. [2] Genome-wide association studies (GWAS) have identified several genetic loci associated with peptic ulcer disease, many of which are linked to H. pylori infection susceptibility, immune response, gastric acid secretion, or gastrointestinal motility. [2]
Specific genes implicated in PUD, and by extension duodenal ulcers, include MUC1, MUC6, FUT2, PSCA, ABO, CDX2, GAST, and CCKBR. [2] For instance, MUC1, MUC6, and FUT2 are associated with susceptibility to H. pylori infection, while PSCA and ABO are proposed to influence the host's response following infection. [2] The ABO blood group system, particularly blood group O, has been linked to a higher risk of peptic ulcers, potentially due to varying susceptibilities and immunological responses to H. pylori. [2]
Two specific single nucleotide polymorphisms (SNPs), rs2976388 in the PSCA gene and rs687621 in the ABO gene, have been consistently associated with duodenal ulcers across different ancestries, including Japanese and European populations. [2] The A allele of rs2976388 is associated with increased PSCA expression, and this increased expression is linked to a decreased risk for PUD, suggesting a protective role for PSCA. [2] Additionally, genetic variants affecting genes like EFNA1 and PTGER4 show pleiotropic effects on duodenal ulcer and gastric cancer, with PUD risk alleles influencing their expression. [1] The genetic architecture of duodenal ulcers shows distinct characteristics compared to gastric ulcers, with duodenal ulcers exhibiting higher SNP-based heritability. [1]
Clinical Relevance
Duodenal ulcers can lead to symptoms such as abdominal pain, nausea, and vomiting. They are typically diagnosed through endoscopic examination. Beyond H. pylori infection, another significant cause of duodenal ulcers is the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin. [3] Treatment often involves eradicating H. pylori infection if present, and reducing acid secretion using medications. Duodenal ulcers can also coexist with or be related to other gastrointestinal disorders, including gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). [2] There is also research exploring connections between peptic ulcer disease and major depression. [2]
Social Importance
Duodenal ulcers represent a considerable public health concern due to their prevalence and potential for complications, including bleeding, perforation, and obstruction. The global burden of peptic ulcer disease has been a subject of population-based studies. [1] Understanding the genetic and environmental factors contributing to duodenal ulcers is crucial for developing targeted prevention strategies, improving diagnostic methods, and personalizing treatment approaches, ultimately aiming to reduce the disease's impact on individuals and healthcare systems.
Methodological and Statistical Considerations
The power to detect pleiotropic effects was limited for some individual digestive disorders due to small case numbers, and an imbalance in sample sizes across different disorders could potentially inflate Type I error rates. [4] Additionally, certain advanced analyses, such as outlier-corrected Mendelian randomization, may have experienced reduced statistical power because of the necessity for sample splitting and the removal of specific genetic variants. [1]
While extensive GWAS datasets were employed for discovery, a notable limitation was the absence of dedicated replication datasets for all genome-wide significant SNPs, particularly for phenotypes like GORD and PGM. [2] This lack of independent validation cohorts can hinder the robust confirmation of genetic associations and their broader applicability across diverse populations beyond the initial discovery samples.
Phenotypic Definition and Generalizability
The definition of phenotypes in these studies was often broad, for example, combining gastric, duodenal, and other peptic ulcer types into a single "peptic ulcer disease" (PUD) category. [2] This inclusive approach meant that the inherent heterogeneity within these conditions, which could influence distinct genetic underpinnings, was not thoroughly investigated. [2] Furthermore, the use of PUD or GERD data as proxies for certain analyses might introduce imprecision in genetic association findings. [5]
A significant constraint is that the primary analyses were conducted on cohorts predominantly of European ancestry, such as the UK Biobank, which is recognized for its volunteer bias. [2] This demographic focus restricts the direct generalizability of the findings to non-European populations and highlights the critical need for further genetic studies in diverse ancestral groups to account for potential confounding effects from population structure. [4]
Unexplored Environmental and Biological Factors
The comprehensive role of environmental factors and their interactions with genetic predispositions could not be fully explored due to the unavailability of key data, such as Helicobacter pylori infection status and detailed microbiome information, for all participants within the UK Biobank cohort. [2] This omission is particularly significant given the established influence of H. pylori in the pathogenesis of peptic ulcer disease, leaving a gap in understanding the full gene-environment interplay. [2]
Further research is warranted to address remaining knowledge gaps, including the need for experimental validation of functional clues identified through bioinformatics analyses. [4] Moreover, the studies did not explicitly investigate the contribution of epigenetic factors, suggesting that more in-depth correlation analyses are required to elucidate their role in the complex etiology of duodenal ulcer. [4] The intriguing potential protective role of duodenal ulcer against gastric cancer also necessitates further dedicated investigation. [1]
Variants
Variants within the ABO and FUT2 genes play a significant role in determining an individual's susceptibility to duodenal ulcer, largely through their influence on blood group and secretor status, which in turn affect the host's interaction with Helicobacter pylori. The ABO gene, responsible for encoding glycosyltransferases that determine the ABO blood group antigens on red blood cells and other cell surfaces, includes variants such as rs8176719, which is the lead variant at the ABO locus and whose deletion allele is known to result in the O blood group. [1] Blood group O is consistently associated with a higher risk of peptic ulcer disease. [1] Similarly, rs687621, an intronic variant in ABO, and rs505922 are in high linkage disequilibrium with rs8176719 and are also associated with peptic ulcer disease, underscoring the role of ABO blood group antigens in host immune responses and susceptibility to infections. [2]
The FUT2 gene encodes fucosyltransferase 2, an enzyme critical for the expression of ABO blood group antigens in secretions (secretor status). Non-secretor status, often influenced by variants like those linked to rs11665674 in the FUT2 gene, is significantly correlated with an increased risk of peptic ulcer disease. [1] This is because FUT2 activity affects the ability of H. pylori to colonize the gastric mucosa; individuals with non-secretor status may have altered mucosal barriers or different immune responses that make them more vulnerable to H. pylori infection, a primary cause of duodenal ulcers. [2] The interplay between ABO blood groups and FUT2 secretor status highlights a complex genetic predisposition to duodenal ulcer, where host factors modulate the impact of environmental agents like H. pylori.
Other genes contribute to duodenal ulcer susceptibility through various mechanisms, including cell growth regulation and gastrointestinal function. The PSCA (Prostate Stem Cell Antigen) gene, for instance, is involved in cell proliferation, adhesion, and apoptosis, and its expression levels are linked to peptic ulcer risk. Variants such as rs71514093, rs2920281, and rs2294008 located within or near PSCA are associated with duodenal ulcer, with increased PSCA expression shown to decrease the risk for peptic ulcer disease. [2] This suggests that PSCA may play a protective role in the gastrointestinal tract, potentially by influencing mucosal integrity or response to injury. [1] Meanwhile, the CCKBR (Cholecystokinin B Receptor) gene, located near rs10500661, encodes a G-protein coupled receptor for gastrin and cholecystokinin, peptides that regulate gastric acid secretion and motility. Variants in CCKBR have been specifically associated with H. pylori-positive peptic ulcer disease, indicating its involvement in the physiological response to infection and its potential as a therapeutic target for ulcer treatment. [2]
Further genetic associations include variants in genes like UBE2V1P4, NALCN-AS1, TTC33, CYP2A7P2, CYP2G1P, CYP2B7P, PRKAA1, JRK, and SEC1P. For example, rs573784774 near UBE2V1P4 (Ubiquitin Conjugating Enzyme E2 V1 Pseudogene 4) and rs78168911 near NALCN-AS1 (NALCN Antisense RNA 1) are implicated, with UBE2V1P4 potentially influencing protein ubiquitination pathways relevant to cellular stress responses in the gut. Variants such as rs3805497 in TTC33 (Tetratricopeptide Repeat Domain 33) and rs573250197 located among the CYP pseudogenes (CYP2A7P2, CYP2G1P, CYP2B7P) suggest roles for protein-protein interactions and xenobiotic metabolism, respectively, in duodenal ulcer pathogenesis. [1] Additionally, rs373477888 in PRKAA1 (Protein Kinase AMP-Activated Catalytic Subunit Alpha 1), a gene central to cellular energy homeostasis, and rs11665674 linked to SEC1P (SEC1 Homolog Pseudogene) highlight diverse biological pathways that collectively contribute to the complex etiology of duodenal ulcer. [1] These genetic variations underscore the multifactorial nature of duodenal ulcer, involving host immunity, gastric physiology, and cellular stress responses.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs71514093 rs2920281 |
PSCA, JRK | duodenal ulcer |
| rs2294008 | JRK, PSCA | gastric carcinoma gastric adenocarcinoma urinary bladder carcinoma duodenal ulcer atrophic gastritis |
| rs573784774 | UBE2V1P4 | duodenal ulcer |
| rs78168911 | NALCN-AS1 | duodenal ulcer |
| rs3805497 | TTC33 | peptic ulcer disease duodenal ulcer |
| rs573250197 | CYP2A7P2, CYP2G1P, CYP2G1P, CYP2B7P, CYP2B7P | duodenal ulcer |
| rs373477888 | PRKAA1 | duodenal ulcer |
| rs11665674 | SEC1P - FUT2 | level of mucin-2 in blood alkaline phosphatase measurement chronic rhinosinusitis intestinal-type alkaline phosphatase measurement duodenal ulcer |
| rs8176719 rs687621 rs505922 |
ABO | venous thromboembolism malaria von Willebrand factor quality factor VIII measurement E-selectin amount |
| rs10500661 | CNGA4 - CCKBR | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease peptic ulcer disease level of gastrin in blood duodenal ulcer |
Definition and Core Characteristics of Duodenal Ulcer
Duodenal ulcer (DU) is precisely defined as a specific manifestation of peptic ulcer disease (PUD), involving open sores that form on the lining of the duodenum, which is the initial segment of the small intestine. [1] PUD itself is recognized as a complex gastrointestinal disorder, with its primary etiological factors being infection with Helicobacter pylori and the regular use of non-steroidal anti-inflammatory drugs (NSAIDs). [2] The progression of an infection-related duodenal ulcer is understood as a multi-step process, commencing with H. pylori infection that subsequently leads to inflammation and damage of the duodenal mucosal lining. [2] Beyond these common causes, duodenal ulcers can also present without clear association to H. pylori infection or NSAID use, representing a distinct clinical challenge. [2]
Classification and Subtypes of Peptic Ulcer Disease
Within the broader nosological framework of peptic ulcer disease, duodenal ulcers are primarily categorized based on their distinct anatomical location. [1] This classification system differentiates duodenal ulcers from gastric ulcers (GU), with the former occurring in the duodenum and the latter in the stomach lining. [1] Other less common ulcer sites, such as gastro-jejunal ulcers, are also recognized as subtypes contributing to the overall spectrum of PUD. [2] For comprehensive epidemiological and genetic studies, PUD cases are often broadly defined by combining individuals diagnosed with any of these major anatomical subtypes, including duodenal ulcer, to capture the full scope of the disease. [1]
Operational Definitions and Diagnostic Criteria in Research
For research applications, particularly in large-scale studies such as genome-wide association studies (GWAS), the operational definition of duodenal ulcer relies on rigorously applied diagnostic criteria. [2] These criteria are typically derived from various robust data sources, including disease-diagnoses phenotypes documented in death registers, self-reported medical conditions, hospital admission records, and primary care records. [2] For instance, in studies utilizing the UK Biobank, duodenal ulcer cases are specifically identified through a designated data field (UKB data field: 131593). [2] Furthermore, international classification systems like ICD9 codes, where 531–534 denote peptic ulcer cases, are frequently employed to standardize the categorization of affected individuals. [2] In genetic analyses, duodenal ulcer status is commonly treated as a binary phenotype, classifying individuals as either affected or unaffected. [6]
Clinical Presentation and Phenotypic Definition
Duodenal ulcer is a specific subtype of peptic ulcer disease (PUD), characterized by acid-induced injury predominantly occurring in the duodenum. [1] This condition is recognized as a complex disorder, with Helicobacter pylori infection and the use of non-steroidal anti-inflammatory drugs (NSAIDs) identified as primary risk factors for its development. [2] While these are common etiologies, clinical presentations of duodenal ulcer not associated with H. pylori infection or NSAID use also exist, presenting distinct diagnostic and therapeutic challenges. [2] For research purposes, cases are often defined based on disease diagnoses obtained from death registers, self-reported health statuses, hospital admissions, or primary care records. [2]
Diagnostic Assessment and Heterogeneity
The diagnostic assessment of duodenal ulcer in scientific studies frequently involves the review of medical records and structured interviews, sometimes supplemented by standardized or self-administered questionnaires to gather detailed phenotypic information. [1] Phenotypes are carefully categorized by the anatomical site of the ulcer, distinguishing duodenal ulcers from gastric ulcers. [1] Official classification systems, such as ICD9, are utilized to identify peptic ulcer cases, which include duodenal ulcers, under specific codes like 531–534. [2] Although gastric and duodenal ulcers share common genetic risk loci, duodenal ulcers exhibit smaller genetic effect sizes and higher polygenicity, suggesting underlying genetic heterogeneity that may influence their presentation and response to treatment. [1]
Clinical Significance and Comorbidities
The accurate identification of a duodenal ulcer carries significant clinical importance, particularly due to its strong association with H. pylori infection, for which eradication therapy is an effective treatment strategy. [2] Furthermore, duodenal ulcer often correlates with other gastrointestinal disorders, including gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). [2] Comorbidity analyses are conducted to determine if the overlap between duodenal ulcer cases and these other digestive conditions, or even depression, is statistically significant, highlighting potential shared pathogenic mechanisms or symptom overlap. [2] Understanding these complex correlations is vital for accurate differential diagnosis and for developing comprehensive management plans that address the patient's overall health. [2]
Genetic Susceptibility
Genetic factors play a significant role in an individual's predisposition to duodenal ulcer. Genome-wide association studies (GWAS) have identified several independent loci associated with peptic ulcer disease (PUD), which includes duodenal ulcer, often linked to host susceptibility to Helicobacter pylori infection, the body's response to infection-related damage, gastric acid secretion, or gastrointestinal motility. [2] Notable genes implicated include MUC1, MUC6, FUT2, PSCA, ABO, CDX2, GAST, and CCKBR, with variants near these genes influencing risk. [2] For instance, specific single nucleotide polymorphisms (rs2976388 and rs687621, also referred to as rs2294008 and rs505922) have been consistently associated with duodenal ulcer development, particularly following H. pylori infection. [2]
Further research has revealed additional genetic insights, with cross-ancestry meta-analyses identifying 25 new loci for PUD, demonstrating high concordance across different ancestral populations. [1] While duodenal ulcers share risk loci with gastric ulcers, the genetic architecture suggests that duodenal ulcers exhibit a higher SNP-based heritability, almost twice that of gastric ulcers, indicating a more direct genetic contribution to their etiology. [1] Additionally, genes such as EFNA1 and PTGER4 show pleiotropic effects, influencing both duodenal ulcer risk and gastric cancer, while variants near EYA1 (specifically rs12678747) are associated with aspirin-induced peptic ulceration. [1]
Environmental Triggers and Pharmacological Factors
Environmental exposures and certain medications are major precipitating factors for duodenal ulcer. Helicobacter pylori infection is recognized as one of the most common causes, directly contributing to the ulceration process. [1] The bacterium colonizes the gastric mucosa, leading to inflammation and disrupting the protective mechanisms of the duodenum, thereby making it vulnerable to acid damage. Another prevalent cause is the use of nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, which can induce ulcers by inhibiting cyclooxygenase enzymes, impairing prostaglandin synthesis, and compromising the mucosal barrier. [1]
The impact of these environmental factors can be substantial. For example, the use of aspirin has a genome-wide significant association with peptic ulceration. [3] While other lifestyle factors like smoking are known risk factors for related gastrointestinal conditions like inflammatory bowel disease, their direct, specific contribution to duodenal ulcer pathogenesis is less detailed in some studies. [2] However, the overarching roles of H. pylori and NSAIDs remain central to the understanding of duodenal ulcer development.
Gene-Environment Interactions and Comorbidities
The development of duodenal ulcer often involves complex interactions between an individual's genetic makeup and environmental triggers, alongside the influence of co-existing health conditions. Host genetic susceptibility significantly modulates the risk associated with Helicobacter pylori infection; for instance, increased gastrin levels induced by H. pylori can interact with altered expression of the CCKBR gene, leading to dysregulated gastric acid secretion and altered cellular responses, including apoptosis, thereby influencing ulcer development. [1] This highlights how genetic variants can modify an individual's physiological response to an infectious agent.
Furthermore, duodenal ulcer is not an isolated condition but often interlinked with other gastrointestinal disorders and systemic health issues. There is a recognized genetic and phenotypic relationship between peptic ulcer disease (which encompasses duodenal ulcer) and conditions such as gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). [2] Studies also indicate a significant connection between these gastrointestinal disorders and major depression, suggesting potential bidirectional causality or pleiotropic genetic effects that contribute to the overall disease landscape. [2]
Etiology and Pathophysiology of Duodenal Ulcers
Duodenal ulcer (DU) represents an acid-induced injury to the digestive tract, specifically occurring in the proximal segment of the duodenum. As a subtype of peptic ulcer disease (PUD), its development is primarily driven by an imbalance between aggressive factors, such as gastric acid and pepsin, and defensive mucosal mechanisms. [1] The two most common causes contributing to this imbalance are infection with Helicobacter pylori (HP) bacteria and the use of nonsteroidal anti-inflammatory drugs (NSAIDs), both of which compromise the integrity of the duodenal lining and exacerbate acid-related damage. [1] This acid-induced injury can lead to significant complications, including bleeding, perforation, or gastric outlet obstruction, highlighting the severe consequences of disrupted gastrointestinal homeostasis. [1]
The pathogenesis of duodenal ulcers also involves complex pathophysiological processes, including host genetic susceptibility and immune responses. Genetic factors play a critical role in determining an individual's vulnerability to PUD, influencing how the body responds to infectious agents like H. pylori and handles the inflammatory processes that ensue. [1] For instance, specific genetic variations can affect the mucosal barrier's resilience or the regulatory mechanisms controlling gastric acid secretion, thereby increasing the risk of ulcer formation even in the presence of common environmental triggers. [2] Furthermore, the immune system's activation in the intestinal mucosa, potentially driven by infections or other stimuli, can contribute to the inflammatory environment conducive to ulcer development. [2]
Genetic Mechanisms and Key Biomolecules
Genetic predisposition significantly influences the susceptibility to duodenal ulcers, with various genes and their products playing crucial roles in disease etiology. Genome-wide association studies (GWAS) have identified several loci associated with PUD, including genes such as MUC1, MUC6, FUT2, PSCA, ABO, CDX2, GAST, and CCKBR. [2] These genes are implicated in diverse biological functions critical for gastrointestinal health, including host susceptibility to Helicobacter pylori infection, the body's ability to counteract infection-related damage, the regulation of gastric acid secretion, and overall gastrointestinal motility. [2] For example, MUC1 and MUC6 encode mucin proteins essential for forming the protective mucus layer, and variations in these genes can alter mucosal defense, with their effect sizes for PUD risk observed to be larger in European populations. [1]
Beyond host defense and motility, specific biomolecules and their regulatory pathways are central to duodenal ulcer development. The hormone gastrin, secreted by stomach G cells, is a potent stimulator of gastric acid secretion. [1] Altered expression in the CCKBR gene, which encodes the cholecystokinin B receptor, can interact with increased gastrin levels induced by H. pylori, leading to dysregulated gastric acid secretion and altered susceptibility to apoptosis in mucosal cells. [1] This intricate interplay between hormonal regulation and cellular fate decisions highlights the molecular complexity underlying ulcer formation. Furthermore, serotonin (5-HT), a neurotransmitter secreted by EC cells, and somatostatin, secreted by stomach D cells, exert diverse gastrointestinal functions, with their regulation being critical in PUD etiology, suggesting a significant role for neuroendocrine signaling in maintaining duodenal health. [1]
Cellular and Tissue-Level Biology
The cellular landscape of the stomach and duodenum plays a critical role in the maintenance of mucosal integrity and the pathogenesis of duodenal ulcers. Specialized cell types, including 5-HT-secreting EC cells, somatostatin-secreting stomach D cells, and stomach tuft cells, have been identified as key players in PUD etiology. [1] Stomach D cells, which produce somatostatin, are particularly important as genetic factors for PUD are enriched in genes highly expressed in these cells, underscoring their regulatory influence on gastric physiology. [1] Tuft cells, recognized as chemosensory epithelial cells, contribute to the immune response by secreting interleukin-25, which drives type 2 immune responses, suggesting a link between mucosal immunity and ulcer development. [1]
The coordinated function and differentiation of these gastrointestinal cells are crucial for maintaining tissue homeostasis. Genetic evidence points to the critical role of gastrointestinal cell differentiation and hormone regulation in PUD etiology. [1] Disruptions in these processes can compromise the delicate balance required for mucosal protection against acid and other damaging agents. For instance, dysregulation in the production of hormones like gastrin and somatostatin can lead to an environment conducive to ulceration, affecting not only the duodenum but also having systemic consequences on digestive function and overall gastrointestinal health. [1]
Interplay with Gastrointestinal Homeostasis and Other Disorders
Duodenal ulcer formation is not an isolated event but rather intricately linked to broader gastrointestinal homeostasis and shares genetic and pathophysiological connections with other digestive disorders. There is a recognized genetic contribution to PUD, as well as to gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), indicating shared underlying pathways or predispositions. [2] While PUD, GORD, and IBS are multifactorial diseases influenced by factors like central nervous system hypervigilance, immune activation, and the microbiome, the genetic landscape reveals commonalities that suggest a complex interplay within the gastrointestinal system. [2]
Furthermore, the genetic architecture of duodenal ulcers demonstrates distinct characteristics compared to gastric ulcers (GU), another major subtype of PUD. Although DUs and GUs share many risk loci, DUs exhibit larger genetic effect sizes and lower polygenicity, implying a more direct genetic influence compared to the higher heterogeneity observed in GUs. [1] Interestingly, some genetic variants associated with PUD, such as those near EFNA1 and PTGER4, exhibit pleiotropic effects and opposing associations with gastric cancer (GC). [1] For example, PUD risk alleles are associated with increased EFNA1 (which suppresses tumor growth) and reduced PTGER4 (which supports tumor growth), suggesting that factors beneficial for ulcer healing might paradoxically impose an increased risk for gastric cancer through altered cell proliferation and angiogenesis. [1]
Host Genetic Susceptibility and Mucosal Barrier Regulation
Duodenal ulcer development is significantly influenced by host genetic factors that regulate mucosal barrier integrity and susceptibility to pathogens. Genes such as MUC1 and MUC6, which encode mucin proteins critical for the protective mucus layer, play a role in the host's response to counteract infection-related damage. [2] Genetic variations in other genes like FUT2, PSCA, ABO, and CDX2 have been associated with peptic ulcer disease, impacting susceptibility to Helicobacter pylori infection, gastric acid secretion, and gastrointestinal motility. [2] Dysregulation in these genes can compromise the duodenal mucosa's ability to withstand acid and enzymatic damage, thereby increasing ulcer risk through altered gene expression or protein function.
Neuroendocrine and Inflammatory Signaling Pathways
The etiology of duodenal ulcers involves intricate neuroendocrine and inflammatory signaling. Key cellular players include 5-HT-secreting enterochromaffin (EC) cells, somatostatin-secreting stomach D cells, and stomach tuft cells, all identified as having a crucial role in peptic ulcer disease. [1] Gastrin, secreted by stomach G cells, stimulates gastric acid secretion, while serotonin (5-HT) from EC cells exerts diverse gastrointestinal functions, contributing to the regulation of the local environment. [1] Furthermore, tuft cells secrete interleukin-25, which drives type 2 immune responses, indicating the involvement of specific immune pathways in ulcer pathogenesis. [1]
Cellular Homeostasis, Repair, and Metabolic Adaptation
Maintaining cellular homeostasis and executing effective repair mechanisms are vital for preventing and healing duodenal ulcers. Genes like EFNA1 and PTGER4 are implicated in processes such as angiogenesis and cell proliferation, which are fundamental for tissue regeneration and ulcer healing. [1] Dysregulation in these pathways, where PUD risk alleles may lead to increased EFNA1 levels and reduced PTGER4 levels, can hinder the healing process, potentially contributing to persistent ulceration . The observed genetic correlations and shared susceptibility loci between PUD and other gastrointestinal disorders, such as gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), suggest common underlying pathogenic pathways, including autophagy and the IL-17/IL-23 axis. [2] Additionally, the nervous system and gastrointestinal tract are linked, with evidence suggesting a bidirectional relationship between PUD/GORD and major depression, highlighting intricate network interactions and pleiotropic effects that contribute to the emergent properties of duodenal ulcer disease. [2]
Genetic Predisposition and Risk Stratification
Genetic factors play a significant role in an individual's susceptibility to duodenal ulcer disease. Genome-wide association studies (GWAS) have identified multiple independent loci associated with peptic ulcer disease (PUD), many of which are specifically relevant to host susceptibility to Helicobacter pylori infection, the host's response to infection-related damage, gastric acid secretion, or gastrointestinal motility. [2] For instance, genes such as MUC1, MUC6, FUT2, PSCA, ABO, CDX2, GAST, and CCKBR have been implicated. [2] Such genetic insights are crucial for risk stratification, enabling the identification of high-risk individuals who may benefit from targeted prevention strategies or more vigilant monitoring for duodenal ulcer development, especially given the rising challenge of antimicrobial resistance in H. pylori. [2]
Furthermore, specific genetic variants have been linked directly to duodenal ulcer. Two notable single nucleotide polymorphisms, rs2294008 and rs505922, were initially identified in a Japanese cohort and subsequently replicated across different ancestries, demonstrating their consistent association with duodenal ulcer development following H. pylori infection. [2] Beyond H. pylori-related ulcers, a GWAS specifically focused on aspirin intake identified a genome-wide significant association for rs12678747 with aspirin-induced peptic ulceration. [3] These findings highlight the potential for personalized medicine approaches, where an individual's genetic profile could inform tailored prevention advice, such as avoiding NSAIDs or recommending specific H. pylori eradication regimens, thus improving patient outcomes and reducing diagnostic and therapeutic challenges associated with non-H. pylori, non-NSAID ulcers. [2]
Comorbidities and Overlapping Phenotypes
Duodenal ulcer disease does not exist in isolation but is often genetically correlated with other common gastrointestinal disorders and even neuropsychiatric conditions. Research indicates significant genetic overlap and associations between PUD and gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). [2] Understanding these overlapping phenotypes is vital for comprehensive patient care, as individuals presenting with one condition may be at an increased risk for another, necessitating a broader diagnostic perspective and integrated management strategies. [2]
Intriguingly, genetic studies have also revealed a connection between PUD and major depression. [2] This association suggests that the clinical relevance of duodenal ulcer extends beyond the gastrointestinal system, potentially involving shared genetic pathways or complex bidirectional relationships between gut health and mental well-being. [2] Clinicians should be aware of these comorbidities, as they can influence patient symptoms, quality of life, and treatment adherence, prompting a holistic approach to patient assessment and care that considers both physical and psychological health aspects.
Pathophysiological Insights and Therapeutic Targets
Genetic studies offer crucial mechanistic insights into duodenal ulcer pathogenesis, which can guide the development of novel therapeutic strategies and improve prognostic assessment. For instance, PUD risk alleles have been linked to increased levels of EFNA1 and reduced levels of PTGER4. [1] Conversely, gastric cancer (GC) risk alleles showed an inverse relationship with these genes, suggesting that alleles protective against PUD might increase GC risk through mechanisms like upregulated cell proliferation and angiogenesis. [1] This complex interplay between PUD and GC risk alleles, alongside the identification of multiple cancer-related genes (e.g., IHH, GNAS, NHEJ1, JUP, MECOM) associated with PUD, provides potential targets for interventions that could influence ulcer healing or alter the long-term outcomes for patients, including their risk of progression to malignancy. [1]
Further mechanistic exploration points to the critical role of specific cell types in PUD etiology, including 5-HT-secreting EC cells, somatostatin-secreting stomach D cells, and stomach tuft cells. [1] These findings deepen the understanding of the physiological processes underlying duodenal ulcer formation and healing, moving beyond the traditional focus on H. pylori and NSAIDs. Such detailed pathophysiological insights can inform the development of more precise diagnostic markers and targeted therapies, improving treatment selection and monitoring strategies for duodenal ulcer patients, particularly for those cases not clearly linked to the primary known risk factors. [2]
Frequently Asked Questions About Duodenal Ulcer
These questions address the most important and specific aspects of duodenal ulcer based on current genetic research.
1. Why do I get ulcers but my friends don't?
Your risk of developing a duodenal ulcer isn't just about environmental factors like H. pylori infection; your genes play a big role too. Genetic differences influence how susceptible you are to infection or how your body responds to damage. For example, variations in genes like MUC1 or FUT2 can affect your likelihood of getting an ulcer compared to others.
2. Is my family's ulcer history important for me?
Yes, a family history of ulcers can definitely increase your personal risk. Duodenal ulcers have higher genetic heritability compared to some other types of ulcers, meaning genetic factors passed down in your family contribute significantly to your susceptibility. If your close relatives have had ulcers, you might share some of these predisposing genetic variations.
3. Does my blood type increase my ulcer risk?
Interestingly, yes, your blood type can influence your risk. People with blood group O, for instance, have been linked to a higher risk of peptic ulcers. This might be because certain blood groups affect your susceptibility to H. pylori infection or how your immune system reacts to the bacteria.
4. Can my kids inherit my chance of ulcers?
Your children can inherit genetic predispositions that increase their risk of developing duodenal ulcers. While it's not a guarantee, if you have these genetic factors, there's a higher chance your children might also carry them. However, whether they actually develop an ulcer will also depend on environmental factors like H. pylori exposure.
5. If I get H. pylori, will I get an ulcer?
Not necessarily. While H. pylori infection is a primary cause, your genetic makeup influences whether the infection leads to an ulcer. Genes like MUC1 and FUT2 affect your susceptibility to the infection itself, and others like PSCA and ABO can influence how your body responds to the bacteria, determining if an ulcer develops.
6. Does my background affect my ulcer risk?
Yes, your ancestry can affect your ulcer risk. Genetic studies have identified specific genetic markers, such as variations in the PSCA and ABO genes, that are consistently linked to duodenal ulcers across different populations, including Japanese and European ancestries. However, there might be other ancestry-specific genetic factors that haven't been fully explored yet.
7. Could a DNA test predict my ulcer risk?
A DNA test could provide insights into your genetic predisposition for duodenal ulcers. Researchers have identified specific genetic variations, like rs2976388 in the PSCA gene or rs687621 in the ABO gene, that are linked to ulcer risk. However, genetics are only one part of the picture, and environmental factors also play a crucial role.
8. Why do some people get H. pylori ulcers easily?
Some individuals are genetically more vulnerable to H. pylori infection and the damage it causes. Variations in genes like MUC1, MUC6, and FUT2 can make you more susceptible to getting infected by H. pylori. Other genes, such as PSCA and ABO, then influence your body's immune response once infected, leading to a higher ulcer risk for some.
9. Are my other gut issues linked to ulcers?
There can be connections between duodenal ulcers and other gastrointestinal conditions like GORD, IBS, and inflammatory bowel disease. This is partly due to shared genetic pathways, where certain genes like EFNA1 and PTGER4 can have pleiotropic effects, meaning they influence the risk for multiple digestive disorders.
10. Can I overcome my family's ulcer history?
While you can't change your genes, you can significantly reduce your risk even with a family history. Understanding your genetic predisposition highlights the importance of managing environmental factors. Avoiding NSAIDs and testing for/treating H. pylori infection are crucial steps that can help you prevent ulcers, despite your inherited susceptibility.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] He Y, et al. East Asian-specific and cross-ancestry genome-wide meta-analyses provide mechanistic insights into peptic ulcer disease. Nat Genet. 2023.
[2] Wu Y, et al. GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. Nat Commun. 2021.
[3] Bourgeois, S. et al. "Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration." EBioMedicine 2021.
[4] Jiang Y, Liu M, Li X, et al. A cross-disorder study to identify causal relationships, shared genetic variants, and genes across 21 digestive disorders. iScience. 2023;26(11):108304.
[5] Adewuyi, E. O., et al. "A large-scale genome-wide cross-trait analysis reveals shared genetic architecture between Alzheimer's disease and gastrointestinal tract disorders." Commun Biol, 2022.
[6] Manry, J., et al. "Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway." Communications Biology, vol. 3, no. 1, 2020, p. 193.